THIRD TRIMESTER Sample Clauses

THIRD TRIMESTER. Between July first and September thirtieth of each year this Agreement is in effect, a volume of two million eighty-eight thousand boxes, or twenty-four percent of the basic annual volume.
Sample 1Sample 2
AutoNDA by SimpleDocs
THIRD TRIMESTER. 62.5 Note: Teacher Day is 8hours 1 Tentative ending day of school year, subject to additional makeup days for inclement weather or other emergency causes, see Article XIII. Schedule A Compensation will be based on the 2012-2013 audit. If the audit comes in $700,000 in the red to $700,000 in the black, employees will receive step compensation in proration to the amount between -$700,000 and +$700,000. CLARKSTON COMMUNITY SCHOOLS Teacher Salary Schedule 2012-13 STEP BA MA MA+30 EDS PHD 1 38,087 41,802 42,846 43,890 46,080 1.5 39,357 43,195 44,275 45,356 47,619 2 40,626 44,588 45,704 46,821 49,157 2.5 41,896 45,980 47,133 48,285 50,694 3 43,166 47,372 48,561 49,748 52,231 3.5 44,436 48,765 49,988 51,211 53,767 4 45,705 50,158 51,415 52,674 55,302 4.5 46,974 51,552 52,844 54,137 56,838 5 48,243 52,945 54,272 55,599 58,374 5.5 49,513 54,338 55,700 57,062 59,910 6 50,782 55,730 57,128 58,525 61,446 6.5 52,052 57,123 58,551 59,989 62,982 7 53,321 58,515 59,973 61,453 64,518 7.5 54,591 59,908 61,406 62,916 66,054 8 55,860 61,301 62,839 64,379 67,590 8.5 57,130 62,694 64,267 65,841 69,126 9 58,399 64,087 65,695 67,303 70,662 9.5 59,669 65,480 67,124 68,767 72,198 10 60,938 66,873 68,552 70,230 73,734 10.5 62,208 68,266 69,980 71,694 75,271 11 63,477 69,659 71,408 73,157 76,807 11.5 64,747 71,052 72,836 74,620 78,343 12 66,017 72,445 74,263 76,083 79,879 12.5 67,286 73,838 75,691 77,546 81,415 13 68,555 75,230 77,119 79,008 82,950 13.5 69,825 76,623 78,548 80,471 84,307 14 71,094 78,016 79,976 81,934 86,023 14.5 72,364 79,409 81,404 83,398 87,560 15 73,633 80,802 82,831 84,861 89,096 15.5 74,904 82,202 84,264 86,326 90,634 16 76,174 83,602 85,696 87,790 92,171 2012-13 SCHEDULE A-1 EXTRACURRICULAR ATHLETICS PAY SCHEDULE Each position listed in Schedule A-1 must have the approval of the building administrator and the Central Office prior to the activity being performed and subsequent payment for same. The following pay schedule is based on the maximum coaching pay of $7,350. Compensation for all coaches will be a percentage of the maximum pay by sport. No current employee on the A-1 schedule shall receive less pay than their 04-05 rate for the same job assignment. These employees will be placed on the A-1 schedule when their pay equals or is greater than their 04-05 pay rate. Individual pay is based on a percentage of the sport pay and coaching experience from year 1 through year 10. Assignments shall be made annually and do not carry tenure in assignment. Sport % of ...
Sample 1
THIRD TRIMESTER. 62.5 Note: Teacher Day is 8hours 1 Tentative ending day of school year, subject to additional makeup days for inclement weather or other emergency causes, see Article XIII.
Sample 1

Related to THIRD TRIMESTER

  • Commercial Milestones In partial consideration of the rights granted by AstraZeneca to Licensee hereunder, Licensee shall pay to AstraZeneca the following payments, which shall be non-refundable, non-creditable and fully earned upon the first achievement of the applicable milestone event:

  • First Commercial Sale The term “

  • Commercial Milestone Payments For each Licensed Product, Licensee shall pay Arvinas the following one-time milestone event payments when the aggregate Net Sales of such Licensed Product in one or more particular country(ies) for a given calendar year (“Annual Net Sales”), where such Licensed Product is a Valid Claim Licensed Product at the time of sale in each of such country(ies), first achieves the corresponding threshold as set forth in this Section 6.3.2 below, subject to the terms of this Section 6.3 and the payment provisions in Article 7 below: Commercial Milestone Event Milestone Event Payment (US$)

  • Development Milestones In addition to its obligations under Paragraph 7.1, LICENSEE specifically commits to achieving the following development milestones in its diligence activities under this AGREEMENT: (a) (b).

  • Development and Regulatory Milestones With respect to each of the following milestones, Ikaria shall pay BioLineRx the corresponding payment set forth below within [**] days after the achievement by Ikaria, its Affiliates or Licensees of such milestone: MILESTONE PAYMENT

  • Regulatory Milestones Celgene shall make the following approval milestone payments to Jounce that are set forth below upon the first achievement by or on behalf of Celgene, its Affiliates or Sublicensees of the Regulatory Milestone Events set forth below with respect to the first Co-Co Product that achieves such event. For clarity, each milestone set forth below shall be due and payable one time only (regardless of the number of Co-Co Products to achieve any such Regulatory Milestone Event). CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “[***]”. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. Regulatory Milestone Event (For the first Co-Co Product that achieves such event) Milestone Payments (in $ millions) [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] For each of Paragraphs (1) - (3) of this Exhibit C-2, the Parties understand and agree that in no event will more than one (1) milestone payment be paid with respect to any specific event triggering a payment under this Jounce Lead Co-Co Agreement.

  • Milestone A principal event specified in the Contract Documents including the Material Completion and Occupancy Date and other events relating to an intermediate completion date or time.

  • Joint Commercialization Committee As of the Effective Date, the Parties have established a joint commercialization committee (the “Joint Commercialization Committee” or the “JCC”), composed of up to [ * ] representatives of each Party, to monitor and discuss the Commercialization of Products at the operational level. Each JCC representative shall have knowledge and expertise in the commercialization of products similar to Products. The JCC shall in particular:

  • Development Milestone Payments In partial consideration for the rights and licenses granted to Coya hereunder, within ten days after the first achievement of each milestone event in a given Indication set forth in this Section 5.2 (Development Milestone Payments) with respect to a Product (each, a “Development Milestone Event”) by or on behalf of Coya or any of its Affiliates or Sublicensees, Coya shall provide ARScience Bio written notice to ARScience Bio identifying the Development Milestone Event achieved. Upon receipt of any such notice of first achievement of a Development Milestone Event by Coya or its Affiliates or Sublicensees, ARScience Bio will promptly invoice Coya for the applicable Development Milestone Event and Coya will make a milestone payment to ARScience Bio in the amount set forth in this Section 5.2 (Development Milestone Payments) corresponding to such Development Milestone Event (each, a “Development Milestone Payment”) within 45 days of receipt of such invoice. On an Indication-by-Indication basis, each Development Milestone Payment shall be payable only upon the first achievement of the corresponding Development Milestone Event by a Product, in any given Indication for which the Development Milestone Events have not been previously achieved (each such Indication, a “New Indication”). No amounts shall be due for subsequent or repeated achievements of such Development Milestone Event with respect to the same or different Mono Product or Combination Product, as applicable, in such Indication. Accordingly and for clarity, the Development Milestone Payment shall be paid only once, when first achieved by Coya, an Affiliate or a Sublicensee, but no payment shall be due if the same milestone is subsequently achieved by one of Coya, an Affiliate or a Sublicensee. For clarity, the amounts owed in Column (a) below shall be due for the first Combination Product to achieve the Development Milestone Events in a New Indication and the amounts owned in Column (c) below shall be due for the first Mono Product to achieve the Development Milestone Events in a New Indication. Any Combination Product or Mono Product to achieve the Development Milestone Events in a New Indication after the first achievement of the Development Milestone Events as described in the foregoing sentence will cause the amounts in Column (b) with respect to a Combination Product and Column (d) with respect to a Mono Product to be due and payable by Coya upon each such occurrence. If the first Product to achieve a Development Milestone Event in any Indication is a Combination Product, the amounts in Column (a) below shall be due and payable by Coya. If the next Product to achieve a Development Milestone Event in a New Indication is a Mono Product, the amounts in Column (c) below would be due and payable by Coya; provided, that if such next Product to achieve a Development Milestone Event in a New Indication is a Combination Product, the amounts in Column (b) would be due and payable by Coya. By way of example, if a Combination Product achieves IND Acceptance in ALS, and is the first Product to achieve a Development Milestone Event under this Agreement, [***] will be due and payable by Coya. If subsequently a Mono Product achieves IND Acceptance in ALS, no Development Milestone Payments will be due and payable by Coya under this Agreement. However, if subsequently any Combination Product achieves IND Acceptance in Alzheimer’s disease, [***] would be due and payable by Coya.

  • Milestone Event Milestone Payment [***] [***]

Time is Money Join Law Insider Premium to draft better contracts faster.